# CardioKol

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cardiokol

- Industry: Software
- Headquarters: Israel
- Website: www.cardiokol.com
- Total disclosed funding: $8M
- Latest round: Seed (Jun 17, 2022)
- Investors on record: 1

## About

Based in Israel, and founded in 2017, CardioKol operates as a telehealth company. The company was founded by Alon Goren, CTO, Yirmi Hauptman, and Pini Sabach. In September 2019, CardioKol raised USD 8 million in seed funding from Kamet Ventures, with participation from individual investors. As of 2022, the company’s CEO is James Amihood.

CardioKol provides a technology that aids in the early detection of atrial fibrillation (AF), which is a condition that results in tens of millions of strokes annually throughout the world. The company’s technology uses voice-based indicators to identify dangerous conditions related to atrial fibrillation.

## Funding rounds

- Seed, Jun 17, 2022, $8M — Kamet Ventures

## Investors

- Kamet Ventures (https://capitalatlas.ai/funds/kamet-ventures) — Seed